(VIANEWS) – The Market ended the session with GENSIGHT BIOLOGICS (SIGHT.PA) rising 15.11% to €0.64 on Wednesday while CAC 40 fell 0.86% to €7,466.66. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system….
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) jumped by a staggering 15.11% to €0.64 at 11:52 EST on Wednesday, after four consecutive sessions in a row of losses. CAC 40 is falling 0.71% to €7,478.26, after two successive sessions in a row of losses. This seems, at the moment, a somewhat bearish trend…
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) fell 9.45% to €0.66 at 11:51 EST on Monday, after two successive sessions in a row of losses. CAC 40 is dropping 0.24% to €7,559.03, following the last session’s upward trend. This seems, so far, a somewhat down trend exchanging session today. About GENSIGHT BIOLOGICS GenSight…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are CROSSWOOD, XXL, and ZAPTEC. Financial Asset Price Change Updated (EST) CROSSWOOD (CROS.PA) 8.00 14.29% 2023-03-31 08:48:00 XXL (XXL.OL) 2.61 13.36% 2023-03-31 11:38:45 ZAPTEC (ZAP.OL) 38.16…
(VIANEWS) – The Market ended the session with GENSIGHT BIOLOGICS (SIGHT.PA) rising 10.21% to €2.40 on Friday while CAC 40 rose 0.81% to €7,322.39. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system….
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) rose by a staggering 10.21% to €2.40 at 15:06 EST on Friday, following the last session’s upward trend. CAC 40 is jumping 0.65% to €7,310.27, after four sequential sessions in a row of gains. This seems, up to now, a somewhat positive trend exchanging session today….
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) slid by a staggering 27.19% in 21 sessions from €3.01 to €2.19 at 15:01 EST on Tuesday, following the last session’s downward trend. CAC 40 is falling 0.11% to €7,070.39, following the last session’s upward trend. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company,…
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) dropped by a staggering 32.65% in 21 sessions from €3.4 to €2.29 at 13:59 EST on Thursday, after three successive sessions in a row of losses. CAC 40 is rising 1.11% to €6,962.11, following the last session’s downward trend. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a…
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) dropped by a staggering 32.66% in 21 sessions from €3.46 to €2.33 at 13:57 EST on Tuesday, after two consecutive sessions in a row of losses. CAC 40 is jumping 0.79% to €7,066.68, after four sequential sessions in a row of losses. About GENSIGHT BIOLOGICS GenSight…
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) slid by a staggering 27.8% in 21 sessions from €3.35 to €2.42 at 16:55 EST on Thursday, after three successive sessions in a row of losses. CAC 40 is jumping 0.05% to €7,328.26, after two consecutive sessions in a row of losses. About GENSIGHT BIOLOGICS GenSight…
